We're always talking about the importance of medication adherence in ensuring high Star Ratings, and recent industry performance data illustrates this relationship firsthand. Using the interactive RxAnte Star Ratings Tool, you can view the correlation between MAPD and PDP plan Star Ratings and medication adherence rates. Curious about how you stack up against similar plans? Set the measure-specific performance sliders to your plans’ Star Ratings to see how you compare.

Each year as Q4 approaches, Medicare Advantage Part D (MAPD) health plans await the release of updated cut points for the approaching Star Year to understand how these changes will impact their Star Ratings. CMS recently released the new 2022 Star Rating cut points, and RxAnte’s client analytics team will be hard at work providing an updated in-depth industry analysis to account for the impact of these changes on MAPD plans’ Star Rating performance.

In last month's blog post, we highlighted the common barriers that Sapna Patel, RPh, Director of Clinical Services, at Mosaic Pharmacy Services sees on a regular basis. We continue our series with additional observations that Sapna and her team experience frequently while trying to support better health outcomes for Mosaic members.

As the Director of Clinical Services at Mosaic Pharmacy Service, Sapna Patel, RPh, is responsible for overseeing the development and delivery of clinical services for all Mosaic members. This month we asked Ms. Patel to share insights on the most common challenges and scenarios her team experiences when working with members and how Mosaic’s high-value pharmacy service helps to support better health outcomes moving forward.

Polypharmacy is a familiar topic for many when discussing adherence and prescribing behavior. With the addition of three polypharmacy-related display measures for the 2022 CMS quality measure performance year, we turned to Tori Erxleben Rush, PharmD, RxAnte Product Director, to learn more about the display measures and their significance to health plans and their members .

When considering the value of medication adherence, we have typically spoken of improving this aspect of healthcare quality in the context of CMS Stars adherence measures; however, research has also illustrated savings in total cost of care through improved medication adherence. Discover how RxAnte's Value of Future Adherence software is providing plans another way to view their members' medication use.

As plans evaluate their pharmacy quality performance, it is important to consider what adjustments might be made to maintain the most effective outreach program to positively impact influence members’ medication use. This month, Luke Ellis, Manager of Client Operations at RxAnte, shares insight into how we develop the best medication adherence program for each health plan client.